FDA Inspection 1162574 — Tom van Meerten, MD, PhD
The FDA completed an inspection of Tom van Meerten, MD, PhD on January 28, 2022 in Groningen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Groningen (Netherlands)
Additional Details
Clinical Investigator (CI)